fda — BT Online — Business Today Online Journal

The Exciting Future of Medicine with Pablo Lapuerta

Pablo Lapuerta, the Executive Vice President and Chief Medical Officer of Lexicon Pharmaceuticals, focuses heavily on genetics and drug development. He discusses the messaging that the pharmaceutical industry needs to do in order to help the public understand the extensive processes behind bringing new drugs to market, improvements that could be made in the FDA’s drug approval process, and a novel drug that he and Lexicon have developed to treat Type I diabetes.

BT Events, Technology, Interviews, Event Coverage, International ConferenceArjun JagjivanApril 15, 2020medicine, pharmaceuticals, biotech, drug, genetics, ethics, fda, Pablo LaPuerta, medical, drugs, healthtech, career

Planet of the Vapes

Worries have stemmed largely from nicotine’s ability to lead troubled teens down a slippery slope in terms of smoking, as well as any unknown effects that e-cigarettes could have on health

BT Breakdowns, Culture, News & AnalysisMark AgostinelliNovember 16, 2018vape, vaping, Juul, juuling, nicotine, smoking, altria, capitalism, fda, market, health, health concerns, regulation